Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03264508 · ClinicalTrials.gov registry record · NA
Passive Heat Therapy and Age-associated Physiological Function
A NA study, sponsored by Douglas Seals.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03264508: Completed NA study, sponsored by Douglas Seals.
NCT03264508 is a NA study that has completed, run by Douglas Seals. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03264508, a NA study, has completed, sponsored by Douglas Seals.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study aims to determine the effects of 8-10 weeks of repeated hot water immersion ("heat therapy") vs. thermoneutral water immersion on vascular function in late middle-aged to older (55-79 years) adults.
Primary Outcome
Measure of endothelial function
Interventions
- BEHAVIORAL Heat therapy
- BEHAVIORAL Thermoneutral water immersion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-10-25 |
| Est. Completion | 2021-06-01 |
| Phase | NA |
What the finished NCT03264508 record still lists
NCT03264508 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Heat therapy is the first listed.
NCT03264508 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03264508 about?
NCT03264508 is a clinical study titled "Passive Heat Therapy and Age-associated Physiological Function". This study aims to determine the effects of 8-10 weeks of repeated hot water immersion ("heat therapy") vs. thermoneutral water immersion on vascular function in late middle-aged to older (55-79 years) adults.
What is the current status of trial NCT03264508?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-10-25. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT03264508?
The interventions under investigation include: Heat therapy (BEHAVIORAL), Thermoneutral water immersion (BEHAVIORAL).
Who is sponsoring clinical trial NCT03264508?
This trial is sponsored by Douglas Seals, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03264508's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI